Cagri 1S Blend typically refers to a research-chemical formulation containing a combination of two weight-management peptides: cagrilintide and semaglutide (often sold previously under the name CagriSema). The 20mg concentration usually means a combination or stacked dosage (e.g., 10mg cagrilintide and 10mg semaglutide).
How it Works
- Semaglutide: A GLP-1 receptor agonist that increases insulin secretion, slows digestion, and reduces appetite by affecting the brain.
- Cagrilintide: A long-acting amylin analog that further suppresses appetite and promotes a feeling of fullness (satiety).
- The Blend: In clinical trials (like the REDEFINE 1 trial), combining these two mechanisms has resulted in significant weight loss results, outperforming either medication alone




Reviews
There are no reviews yet.